AI Article Synopsis

  • A novel Electrochemiluminescence (ECL) biosensing platform was developed using Glutathione-Au nanoclusters on reduced graphene oxide (GSH-Au NCs@rGO) and copper oxide functionalized Au nanoparticles (Au@CuO) as a quenching probe.
  • The GSH-Au NCs enhance ECL signal intensity by improving luminophore support and facilitating mass transfer, while Au@CuO enables effective resonance energy transfer to quench the signal for more accurate trace detection.
  • This biosensing platform demonstrated a low detection limit of 54.95 fg/mL for cardiac troponin I (cTnI), showing potential for sensitive biomarker

Article Abstract

A "signal-off" Electrochemiluminescence (ECL) biosensing platform based on Glutathione-Au nanoclusters covered reduced graphene oxide (GSH-Au NCs@rGO) and Au nanoparticles functionalized copper oxide (Au@CuO) was fabricated. The GSH ligand protected Au NCs were spontaneously adsorbed on the rGO surface via Van der Waals force. As ECL emitters, GSH-Au NCs@rGO not only support more luminophores and immobilization of bioreceptor units also facilitates mass transfer, accelerating ECL excitation to obtain a higher ECL signal intensity. Remarkably, Au@CuO with good biocompatibility was first applied as a quenching probe. Au@CuO (acceptor)-dependent resonance energy transfers (RET) with GSH-Au NCs@rGO (donor) could effectively quenched the ECL intensity to a reasonable range for requirements of trace analysis. The proposed ECL biosensing platform was evaluated with cardiac troponin I (cTnI) as a model analyte, achieving a low detection limit of 54.95 fg/mL. This strategy may provide as new approaches for the sensitive detection of biomarkers in the early clinical diagnosis of diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.talanta.2022.123649DOI Listing

Publication Analysis

Top Keywords

biosensing platform
12
gsh-au ncs@rgo
12
"signal-off" electrochemiluminescence
8
platform based
8
functionalized copper
8
copper oxide
8
ecl biosensing
8
ecl
6
electrochemiluminescence biosensing
4
based high
4

Similar Publications

Dual Pathways of Photorelease Carbon Monoxide via Photosensitization for Tumor Treatment.

J Am Chem Soc

January 2025

State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Centre for New Organic Matter, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Research Centre for Analytical Sciences, College of Chemistry, School of Medicine and Frontiers Science Center for Cell Responses, Nankai University, Tianjin 300071, P. R. China.

Carbon monoxide (CO) gas therapy, as an emerging therapeutic strategy, is promising in tumor treatment. However, the development of a red or near-infrared light-driven efficient CO release strategy is still challenging due to the limited physicochemical characteristics of the photoactivated carbon monoxide-releasing molecules (photoCORMs). Here, we discovered a novel photorelease CO mechanism that involved dual pathways of CO release via photosensitization.

View Article and Find Full Text PDF

Advancements in plasmonic sensing require simultaneous detection capability that ensures large-scale detection with reduced losses. In this work, we propose a new solid-core fiber-based refractive index (RI) sensor with an ultra-broad detection range. The proposed fiber consists of a relatively simple single-ring cladding with six circular tubes in which the light is guided in the core based on the inhibited-coupling (IC) mechanism.

View Article and Find Full Text PDF

Film-coupled plasmonic resonators offer efficient platforms for light enhancement due to the excitation of gap surface plasmons (GSPs) at metal-insulator-metal interfaces, where electromagnetic energy is stored within the spacer. In applications like biosensing and spontaneous emission control, spatial overlap between the target molecule and plasmonic hotspots is essential. Here, we propose utilizing the controllable, efficient light enhancement capabilities of a specifically designed GSP disk resonator for biosensing and spontaneous emission enhancement.

View Article and Find Full Text PDF

Monitoring of inflammatory preterm responses via myometrial cell based multimodal electrophysiological and optical biosensing platform.

Biosens Bioelectron

January 2025

Department of Chemistry, ZJU-Hangzhou Global Scientific and Technological Innovation Center, School of Medicine, Zhejiang University, Hangzhou, 310058, China; General Surgery Department, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children's Health, Hangzhou, 310052, China. Electronic address:

Preterm birth (PTB) remains a leading cause of neonatal morbidity and mortality, with inflammation-induced PTB posing a significant challenge due to its complex pathophysiology. To address this, we developed an in vitro platform utilizing hTERT-immortalized human myometrial (hTERT-HM) cells integrated with a multielectrode array (MEA) biosensing system and optical calcium imaging. Compared to primary uterine myometrial cells, hTERT-HM cells exhibit superior reproducibility, high scalability, and convenient manipulation, facilitating the consistent and large-scale investigations.

View Article and Find Full Text PDF

Electrochemical capacitance-based aptasensor for HER2 detection.

Biomed Microdevices

January 2025

Department of Physics, Faculty of Philosophy, Science and Letter, University of São Paulo, Ribeirão Preto, SP, 14040-901, Brazil.

The overexpression of Human Epidermal Growth Factor Receptor 2 (HER2) protein is specifically related to tumor cell proliferation in breast cancers. Its presence in biological serum samples indicates presence or progression of cancer, becoming a promise biomarker. However, their detection needs a simple and high accuracy platform.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!